Primary |
Product Used For Unknown Indication |
49.9% |
Hypertension |
15.4% |
Drug Use For Unknown Indication |
7.6% |
Atrial Fibrillation |
7.1% |
Intentional Overdose |
2.9% |
Arrhythmia |
2.3% |
Suicide Attempt |
1.9% |
Angina Pectoris |
1.8% |
Cardiac Failure |
1.7% |
Blood Pressure |
1.3% |
Tachycardia |
1.2% |
Myocardial Infarction |
1.0% |
Cardiac Disorder |
0.9% |
Myocardial Ischaemia |
0.9% |
Anxiety |
0.8% |
Coronary Artery Disease |
0.8% |
Completed Suicide |
0.7% |
Erythema Multiforme |
0.7% |
Overdose |
0.7% |
Blood Pressure Increased |
0.6% |
|
Toxicity To Various Agents |
32.2% |
Poisoning |
8.1% |
Completed Suicide |
6.2% |
Respiratory Arrest |
5.2% |
Vomiting |
5.2% |
Cardiac Arrest |
3.8% |
Drug Interaction |
3.8% |
Hypotension |
3.8% |
Shock |
3.8% |
Suicide Attempt |
3.8% |
Hepatotoxicity |
2.8% |
Syncope |
2.8% |
Urticaria |
2.8% |
Acute Generalised Exanthematous Pustulosis |
2.4% |
Intentional Overdose |
2.4% |
Overdose |
2.4% |
Sinus Bradycardia |
2.4% |
Thrombocytopenia |
2.4% |
Bradycardia |
1.9% |
Oesophagitis |
1.9% |
|
Secondary |
Product Used For Unknown Indication |
31.5% |
Hypertension |
21.5% |
Drug Use For Unknown Indication |
6.9% |
Atrial Fibrillation |
5.3% |
Rheumatoid Arthritis |
3.6% |
Myocardial Ischaemia |
3.1% |
Hypercholesterolaemia |
2.8% |
Blood Pressure |
2.6% |
Anaesthesia |
2.5% |
Suicide Attempt |
2.5% |
Pain |
2.4% |
Angina Pectoris |
2.1% |
Ischaemic Cardiomyopathy |
2.0% |
Asthma |
1.9% |
Diabetes Mellitus |
1.9% |
Duodenal Ulcer |
1.7% |
Muscle Relaxant Therapy |
1.7% |
Cardiac Failure |
1.5% |
Chronic Obstructive Pulmonary Disease |
1.3% |
Arrhythmia |
1.2% |
|
Completed Suicide |
12.4% |
Rhabdomyolysis |
11.7% |
Renal Failure |
8.0% |
Syncope |
8.0% |
Vomiting |
6.6% |
Vision Blurred |
5.8% |
Overdose |
5.1% |
Suicide Attempt |
5.1% |
Mental Disorder |
4.4% |
Cardiac Arrest |
3.6% |
Hyperkalaemia |
3.6% |
Sepsis |
3.6% |
Bradycardia |
2.9% |
Multiple Drug Overdose |
2.9% |
Myopathy |
2.9% |
Respiratory Arrest |
2.9% |
Shock |
2.9% |
Sick Sinus Syndrome |
2.9% |
Atrial Fibrillation |
2.2% |
Blood Bilirubin Increased |
2.2% |
|
Concomitant |
Drug Use For Unknown Indication |
26.2% |
Hypertension |
13.8% |
Product Used For Unknown Indication |
13.1% |
Blood Pressure |
5.3% |
Diabetes Mellitus |
5.2% |
Cardiac Disorder |
4.1% |
Pain |
4.0% |
Rheumatoid Arthritis |
3.6% |
Angina Pectoris |
3.3% |
Osteoporosis |
3.2% |
Prophylaxis |
3.2% |
Type 2 Diabetes Mellitus |
2.0% |
Asthma |
1.9% |
Atrial Fibrillation |
1.9% |
Blood Cholesterol Increased |
1.8% |
Hypercholesterolaemia |
1.7% |
Constipation |
1.6% |
Depression |
1.5% |
Muscle Spasms |
1.4% |
Insomnia |
1.2% |
|
Vomiting |
12.1% |
Rhabdomyolysis |
11.1% |
Weight Decreased |
8.5% |
Weight Increased |
8.2% |
Tremor |
4.6% |
Wrist Fracture |
4.6% |
Pneumonia |
4.4% |
Renal Failure |
4.4% |
Ventricular Tachycardia |
4.1% |
Death |
3.9% |
Syncope |
3.9% |
Myalgia |
3.6% |
Somnolence |
3.6% |
Urinary Tract Infection |
3.6% |
Vitamin D Deficiency |
3.6% |
Myocardial Infarction |
3.3% |
Toxic Epidermal Necrolysis |
3.3% |
Drug Ineffective |
3.1% |
Hypotension |
3.1% |
Nausea |
3.1% |
|
Interacting |
Drug Use For Unknown Indication |
17.4% |
Atrial Fibrillation |
13.0% |
Atrial Flutter |
5.8% |
Cardiac Failure |
5.8% |
Facial Neuralgia |
5.8% |
Prophylaxis |
5.8% |
Angina Pectoris |
4.3% |
Heart Transplant |
4.3% |
Hypertension |
4.3% |
Product Used For Unknown Indication |
4.3% |
Abnormal Behaviour |
2.9% |
Cardiac Failure Congestive |
2.9% |
Cardiac Valve Prosthesis User |
2.9% |
Depression |
2.9% |
Device Related Infection |
2.9% |
Drug Dependence |
2.9% |
Heart Rate Increased |
2.9% |
Hypokalaemia |
2.9% |
Oral Candidiasis |
2.9% |
Parkinson's Disease |
2.9% |
|
Drug Interaction |
16.7% |
Convulsion |
8.3% |
Muscle Rupture |
8.3% |
Paralysis |
8.3% |
Renal Failure Acute |
8.3% |
Ventricular Fibrillation |
8.3% |
Vomiting |
8.3% |
Circulatory Collapse |
4.2% |
Drug Toxicity |
4.2% |
Hypotension |
4.2% |
Incorrect Dose Administered |
4.2% |
Oedema Peripheral |
4.2% |
Rhabdomyolysis |
4.2% |
Sinus Arrest |
4.2% |
Weight Increased |
4.2% |
|